Clinical trial

N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes Mellitus

NCT05745090

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2022-11-10

PhaseN/A

Study timeline

Study start (actual)2022-11-10Date precision: day

Registry last updated2024-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2diabetesunresolved

Heart Failureunresolved

Cardiovascular Complicationunresolved

Interventions

Sponsors & collaborators

Singapore General Hospitallead sponsor

Roche Diagnostics GmbHcollaborator

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05745090 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.